NW-3509

· Newron Pharmaceuticals SPA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NW-3509, covering 2018-06-19 to 2018-06-19. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects [Phase 1]